Home > Income Statement > MARKSANS PHARMA

MARKSANS PHARMA
Revenue

    Back to Income Statement
MARKSANS PHARMA is part of below Screeners ↓
Top Small Cap Stocks with Best Fundamentals
Best Quarterly Growth Small Cap Stocks
COMMUNITY POLL
for MARKSANS PHARMA
Please provide your vote to see the results

MARKSANS PHARMA Last 5 Year Revenue History

[Consolidated]

Mar2026Mar2025Mar2024Mar2023Mar2022
Net Sales ₹2,623 Cr₹2,177 Cr₹1,852 Cr₹1,491 Cr₹1,376 Cr

What is the latest Revenue of MARKSANS PHARMA ?

The latest Revenue ratio of MARKSANS PHARMA is ₹2,623 Cr based on Mar2026 Consolidated results.
Year Revenue
Mar2026₹2,623 Cr
Mar2025₹2,177 Cr
Mar2024₹1,852 Cr
Mar2023₹1,491 Cr
Mar2022₹1,376 Cr

How is Revenue of MARKSANS PHARMA Trending?

Years Revenue % Change
Mar2026 ₹2,623 Cr
20.46
Mar2025 ₹2,177 Cr
17.56
Mar2024 ₹1,852 Cr
24.23
Mar2023 ₹1,491 Cr
8.33
Mar2022 ₹1,376 Cr -

Compare Revenue of peers of MARKSANS PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
MARKSANS PHARMA ₹12,639.7 Cr 1.1% -0.3% 21.9% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹465,471.0 Cr -0.4% 0.9% 19.6% Stock Analytics
DIVIS LABORATORIES ₹226,631.0 Cr -1.2% 21.1% 29.7% Stock Analytics
TORRENT PHARMACEUTICALS ₹185,157.0 Cr -2.3% 0.3% 34.8% Stock Analytics
CIPLA ₹118,108.0 Cr 0.7% 1.5% -2% Stock Analytics
DR REDDYS LABORATORIES ₹100,578.0 Cr -0.3% -7.1% -3.9% Stock Analytics


MARKSANS PHARMA Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
MARKSANS PHARMA

1.1%

-0.3%

21.9%

SENSEX

-0.4%

0.8%

-3%


You may also like the below Video Courses